The chemical class denoted as LOC728392 Inhibitors is distinguished by its specific interaction with a biomolecule identified as LOC728392. Although the precise function and role of LOC728392 in cellular processes remain not fully elucidated, the inhibitors developed for this class are strategically designed molecules aimed at modulating the activity or function of LOC728392, thereby exhibiting an inhibitory effect. Researchers investigating LOC728392 Inhibitors employ an integrative approach, combining structural biology, medicinal chemistry, and computational techniques to unravel the intricate details of the molecular interactions between the inhibitors and LOC728392, shedding light on the potential impact of these compounds on cellular pathways.
Structurally, LOC728392 Inhibitors are meticulously crafted compounds with distinct molecular features tailored to facilitate selective binding to LOC728392. This specificity is crucial to minimize unintended effects on other cellular components, ensuring a targeted and focused impact. The development of inhibitors within this chemical class involves the optimization of pharmacokinetic properties and exploration of structure-activity relationships, as scientists aim to refine the molecular design for enhanced efficacy. As our understanding of LOC728392 Inhibitors advances, the insights gained contribute to a broader comprehension of cellular regulatory mechanisms and the potential roles of LOC728392 in various biological contexts. The exploration of LOC728392 Inhibitors thus represents a significant avenue for expanding fundamental knowledge in cellular biology and molecular pharmacology.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $73.00 $238.00 $717.00 $2522.00 $21420.00 | 53 | |
Actinomycin D intercalates into DNA, inhibiting transcription initiation and elongation, which could reduce LOC728392 expression. | ||||||
α-Amanitin | 23109-05-9 | sc-202440 sc-202440A | 1 mg 5 mg | $260.00 $1029.00 | 26 | |
α-Amanitin inhibits RNA polymerase II, which is responsible for mRNA synthesis, potentially decreasing LOC728392 expression. | ||||||
Triptolide | 38748-32-2 | sc-200122 sc-200122A | 1 mg 5 mg | $88.00 $200.00 | 13 | |
Triptolide has been shown to inhibit the transcription of various genes, which may include LOC728392. | ||||||
DRB | 53-85-0 | sc-200581 sc-200581A sc-200581B sc-200581C | 10 mg 50 mg 100 mg 250 mg | $42.00 $185.00 $310.00 $650.00 | 6 | |
DRB inhibits RNA polymerase II transcription elongation, potentially reducing LOC728392 expression. | ||||||
Flavopiridol Hydrochloride | 131740-09-5 | sc-207687 | 10 mg | $311.00 | ||
Flavopiridol inhibits cyclin-dependent kinases, which are necessary for RNA polymerase II-based transcription. | ||||||
Cordycepin | 73-03-0 | sc-203902 | 10 mg | $99.00 | 5 | |
Cordycepin, an adenosine analog, can terminate RNA chain elongation, possibly affecting LOC728392 expression. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
Trichostatin A inhibits histone deacetylase, affecting chromatin structure and possibly decreasing gene expression, including LOC728392. | ||||||
Leptomycin B | 87081-35-4 | sc-358688 sc-358688A sc-358688B | 50 µg 500 µg 2.5 mg | $105.00 $408.00 $1224.00 | 35 | |
Leptomycin B inhibits nuclear export of mRNA, which could indirectly reduce expression of genes like LOC728392. | ||||||
(±)-JQ1 | 1268524-69-1 | sc-472932 sc-472932A | 5 mg 25 mg | $226.00 $846.00 | 1 | |
JQ1 inhibits BET bromodomain proteins, which may downregulate expression of certain genes, possibly including LOC728392. | ||||||
Mithramycin A | 18378-89-7 | sc-200909 | 1 mg | $54.00 | 6 | |
Mithramycin binds to GC-rich DNA sequences, inhibiting transcription and potentially affecting LOC728392 expression. | ||||||